Skip to main content

Select Drug Profiles

Perspectives, Health Policy and Reform

The Health Reform Law: Key Changes to Be Implemented in 2010

Kip Piper, MA, FACHE

Correspondence: Article Supported by a Pharmaceutical Company Raises Concern

Practice Management

Bundled Payment: A Promising Initiative of Payment Reform

Practice Management

Impact of 2 Copay Waivers in a Generic Incentive Program

Anthony F. Liu, MSCS, Tom Jecklin, Geoffery Lee, James Hogan

Conference Highlights Digestive Disease Week

New Approaches to Treating HCV Infection

Caroline Helwick

Conference Highlights AMCP

AMCP HIGHLIGHTS

Promising New Approaches to Multiple Sclerosis Medications: AAN 2010

Original Research

Prevalence of Treated Bipolar Disorders and Associated Comorbidities in Managed Care and Medicaid Populations

Jeff Jianfei Guo, BPharm, PhD, Nick C. Patel, PharmD, PhD, Hong Li, PhD, Paul E. Keck Jr., MD

Stakeholder Perspective

Bipolar Disorder Prevalence Often Underestimated

by Nirav R. Shah, MD,MPH

Practice Management

Health Benefit Coverage, Reimbursement, and Influences on Traditional Pharmaceutical Channels

F. Randy Vogenberg, PhD, FASHP

Stakeholder Perspective

The Many Challenges of Pay-for-Performance Programs

by Gary M. Owens, MD

Practice Management

Impact of Etanercept Treatment on Absenteeism and Productivity: The Work Loss and Productivity Survey

Denise Globe, PhD, Peter Mazonson, MD, MBA, Chris Santas, MBA, Regina Murphy, MBA, Annie Cheng, Xingyue Huang, PhD, Arthur Kavanaugh, MD

Stakeholder Perspective

What Is the Value of Specialty Pharmaceuticals?

Page 243 of 244
Results 2421 - 2430 of 2434